Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Q-Cells Reverses To Loss In 2011 - Quick Facts

Q-Cells SE (QCLSF.PK) published its unaudited annual results, reporting fiscal 2011 net loss of 845.8 million euros, as against a profit of 18.9 million euros a year ago. Loss before interest and tax amounted to 717.4 million euros in 2011, due to the unexpectedly difficult economic environment and extraordinary items, while in 2010 EBIT had come to 82.3 million euros.

The company noted that it was forced among others to revise down the value of tangible and intangible assets by 398.5 million euros and take 129.1 million euros in impairment charges on inventories.

Fiscal 2011 sales totaled 1.02 billion euros, thereby surpassing its target of more than 1 billion euros, while the prior year's sales amounted to 1.35 billion euros. Production volumes for 2011 came to around 783 megawatt peak or MWp.

Q-CELLS sees another loss making year in 2012, following intense competitive pressure and consolidation. However, after implementing the financial restructuring and medium-term business plan, the company is expected to return to a positive EBITDA for fiscal 2013.

Click here to receive FREE breaking news email alerts for Q-Cells SE and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.